R Lingam1, A Simmons, N Andrews, E Miller, J Stowe, B Taylor. 1. Centre for Community Child Health, Royal Free and University College Medical School, Royal Free Campus, University College London, London NW3 2PF.
Abstract
BACKGROUND: The recorded prevalence of autistic spectrum disorders has risen over recent decades. Measles, mumps and rubella (MMR) vaccine has been blamed, by causing a "new variant" form of "regressive autism" associated with "autistic enterocolitis". AIMS: To estimate the prevalence of autism and to assess any changes in parental perception regarding the onset or causes of autism. METHODS AND RESULTS: A total of 567 children with autistic spectrum disorder in five districts in north east London were identified, born 1979-98. Reported autism, excluding the 94 cases of Asperger's syndrome, increased by year of birth until 1992, since when prevalence has plateaued. This flattening off persisted after allowing for expected delay in diagnosis in more recent birth cohorts. The age at diagnosis of autistic spectrum disorder was estimated to have decreased per five year period since 1983, by 8.7% for childhood autism and by 11.0% for atypical autism. There was some evidence that MMR was more likely to be mentioned as a trigger after August 1997 than before. CONCLUSIONS: The prevalence of autism, which was apparently rising from 1979 to 1992, reached a plateau from 1992 to 1996 at a rate of some 2.6 per 1000 live births. This levelling off, together with the reducing age at diagnosis, suggests that the earlier recorded rise in prevalence was not a real increase but was likely due to factors such as increased recognition, a greater willingness on the part of educationalists and families to accept the diagnostic label, and better recording systems. The proportion of parents attributing their child's autism to MMR appears to have increased since August 1997.
BACKGROUND: The recorded prevalence of autistic spectrum disorders has risen over recent decades. Measles, mumps and rubella (MMR) vaccine has been blamed, by causing a "new variant" form of "regressive autism" associated with "autistic enterocolitis". AIMS: To estimate the prevalence of autism and to assess any changes in parental perception regarding the onset or causes of autism. METHODS AND RESULTS: A total of 567 children with autistic spectrum disorder in five districts in north east London were identified, born 1979-98. Reported autism, excluding the 94 cases of Asperger's syndrome, increased by year of birth until 1992, since when prevalence has plateaued. This flattening off persisted after allowing for expected delay in diagnosis in more recent birth cohorts. The age at diagnosis of autistic spectrum disorder was estimated to have decreased per five year period since 1983, by 8.7% for childhood autism and by 11.0% for atypical autism. There was some evidence that MMR was more likely to be mentioned as a trigger after August 1997 than before. CONCLUSIONS: The prevalence of autism, which was apparently rising from 1979 to 1992, reached a plateau from 1992 to 1996 at a rate of some 2.6 per 1000 live births. This levelling off, together with the reducing age at diagnosis, suggests that the earlier recorded rise in prevalence was not a real increase but was likely due to factors such as increased recognition, a greater willingness on the part of educationalists and families to accept the diagnostic label, and better recording systems. The proportion of parents attributing their child's autism to MMR appears to have increased since August 1997.
Authors: G Baird; T Charman; S Baron-Cohen; A Cox; J Swettenham; S Wheelwright; A Drew Journal: J Am Acad Child Adolesc Psychiatry Date: 2000-06 Impact factor: 8.829
Authors: A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith Journal: Lancet Date: 1998-02-28 Impact factor: 79.321
Authors: Jennifer Richler; Rhiannon Luyster; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord Journal: J Autism Dev Disord Date: 2006-04
Authors: Helen Coo; Hélène Ouellette-Kuntz; Jennifer E V Lloyd; Liza Kasmara; Jeanette J A Holden; M E Suzanne Lewis Journal: J Autism Dev Disord Date: 2007-11-02
Authors: Hélène M J Ouellette-Kuntz; Helen Coo; Miu Lam; C T Yu; Marlene M Breitenbach; Paula E Hennessey; Jeanette J A Holden; Hilary K Brown; Andrea L Noonan; Robert B Gauthier; Lori R Crews Journal: Can J Public Health Date: 2009 Jul-Aug
Authors: Alice S Carter; David O Black; Sonia Tewani; Christine E Connolly; Mary Beth Kadlec; Helen Tager-Flusberg Journal: J Autism Dev Disord Date: 2007-01-10
Authors: Hélène Ouellette-Kuntz; Helen Coo; Jennifer E V Lloyd; Liza Kasmara; Jeanette J A Holden; M E Suzanne Lewis Journal: J Autism Dev Disord Date: 2007-01-11
Authors: Emily Jane Woo; Robert Ball; Ann Bostrom; Sean V Shadomy; Leslie K Ball; Geoffrey Evans; Miles Braun Journal: Am J Public Health Date: 2004-06 Impact factor: 9.308